Effect of Isoflurane on Tissue Doppler Imaging of Mitral Annulus During Cardiac Surgery

Study Overview
=================
Brief Summary
-----------------
The purpose of this study is to determine Isoflurane's dose-dependent effect on left ventricular (LV) systolic function in cardiac surgery. The change of tissue Doppler imaging (TDI) of lateral mitral valve annular systolic velocity at three different isoflurane concentrations would be analyzed by using intraoperative transesophageal echocardiography (TEE) in cardiac surgery patients.

Detailed Description
-----------------
Isoflurane is widely used in cardiac surgery patients due to its beneficial effects, but many studies have shown that isoflurane reduces myocardial contractility in a dose-dependent manner, and compromises left ventricular (LV) function. Tissue Doppler imaging (TDI) of mitral annular velocity during the cardiac cycle has been introduced as a reliable method for analysis of systolic and diastolic LV long-axis function. Efficacy of systolic and diastolic TDI profiles, including systole (S'), early early relaxation (E')and atrial contraction (A') have been suggested to be useful in predicting the impact of isoflurane on LV systolic and diastolic function. The investigators hypothesized that isoflurane, even at a clinical dosage, would affects intraoperative LV systolic function in a dose-dependent manner and thus produce significant changes int the TDI profiles of systolic mitral annular velocity (S'). So the investigators planned to study the changes in S' of lateral mitral annulus at the clinical isoflurane dosage during remifentanil based anesthesia for cardiac surgery.

Official Title
-----------------
Effect of Isoflurane on Tissue Doppler Imaging of Mitral Annulus During Cardiac Surgery

Conditions
-----------------
Valvular Heart Disease, Ischemic Heart Disease

Intervention / Treatment
-----------------
* Drug: Isoflurane 1.0 MAC
* Drug: Isoflurane 1.5 MAC
* Drug: Isoflurane 2.0 MAC


Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: patients undergoing cardiac surgery Exclusion Criteria: low ejection fraction < 50% in preoperative transthoracic echocardiography atrial fibrillation pacemaker pericardial and infiltrative myocardial disease mitral annular calcification, surgical rings, prosthetic mitral valves lateral left ventricular regional wall motion abnormality esophageal spasm, stricture, laceration, perforation, and diverticulum diaphragmatic hernia history of extensive radiation to mediastinum upper gastrointestinal bleeding

Ages Eligible for Study
-----------------
Minimum Age: 20 Years
Maximum Age: 65 Years

Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
No

Study Plan
=================
How is the study designed?
-----------------

Design Details

Primary Purpose: Treatment
Allocation: Non-Randomized
Intervention Model: Parallel Assignment
Masking: Double


Arms and Interventions

| Participant Group/Arm | Intervention/Treatment |
| --- | --- |
| Experimental: Isoflurane 1.0 MAC<br>10 min-inhalation of each concentration of isoflurane, 1.0 MAC | Drug: Isoflurane 1.0 MAC<br>* 10 min-inhalation of each concentration of isoflurane, 1.0 MAC<br>|
| Experimental: Isoflurane 1.5 MAC<br>10 min-inhalation of each concentration of isoflurane, 1.5 MAC | Drug: Isoflurane 1.5 MAC<br>* 10 min-inhalation of each concentration of isoflurane, 1.5 MAC<br>|
| Experimental: Isoflurane 2.0 MAC<br>10 min-inhalation of each concentration of isoflurane, 2.0 MAC | Drug: Isoflurane 2.0 MAC<br>* 10 min-inhalation of each concentration of isoflurane, 2.0 MAC<br>|

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Peak mitral annular velocity during systole(S') | By using pulsed Doppler with the sample volume positioned at the lateral mitral valve (MV)ring in the midesophageal 4-chamber view, S' would be determined just after the 10 min-exposure to each concentration of isoflurane, 1.0 MAC, 1.5 MAC and 2.0 MAC (T1, T2 and T3, respectively) | after 10 min exposure to isoflurane 1.0 MAC, 1.5 MAC and 2.0 MAC | 

Secondary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| ejection fraction(EF) | By using modified Simpson technique in the midesophageal 4-chamber view, EF would be determined just after the 10 min-exposure to each concentration of isoflurane 1.0 MAC, 1.5 MAC and 2.0 MAC | after 10 min exposure to isoflurane 1.0 MAC, 1.5 MAC and 2.0 MAC | 
| bispectral index(BIS) | BIS would be determined just after the 10 min-exposure to each concentration of isoflurane 1.0 MAC, 1.5 MAC and 2.0 MAC | after 10 min exposure to isoflurane 1.0 MAC, 1.5 MAC and 2.0 MAC | 
| peak velocity of mitral inflow during early relaxation(E) | By using pulsed Doppler with the sample volume positioned at the IMV opening in the midesophageal 4-chamber view, E' would be determined just after the 10 min-exposure to each concentration of isoflurane, 1.0 MAC, 1.5 MAC and 2.0 MAC(T1, T2 and T3, respectively) | after 10 min exposure to isoflurane 1.0 MAC, 1.5 MAC and 2.0 MAC | 
| peak velocity of mitral inflow during atrial contraction(A) | By using pulsed Doppler with the sample volume positioned at the tip of MV opening in the midesophageal 4-chamber view, A would be determined just after the 10 min-exposure to each concentration of isoflurane, 1.0 MAC, 1.5 MAC and 2.0 MAC(T1, T2 and T3, respectively) | after 10 min exposure to isoflurane 1.0 MAC, 1.5 MAC and 2.0 MAC | 
| Peak mitral annular velocity during early diastole(E') | By using pulsed Doppler with the sample volume positioned at the lateral MV ring | after 10 min exposure to isoflurane 1.0 MAC, 1.5 MAC and 2.0 MAC | 
| Peak mitral annular velocity during atrial contraction(A') | By using pulsed Doppler with the sample volume positioned at the lateral MV ring | after 10 min exposure to isoflurane 1.0 MAC, 1.5 MAC and 2.0 MAC | 

 Terms related to the study
=================
Keywords Provided by Centre Hospitalier Valida
-----------------
mitral valve annular velocity, tissue Doppler imaging, Monitoring, echocardiography, Isoflurane